[18F]NOS
[18F]NOS is a pharmaceutical drug with 8 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
5
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT
Neuroinflammation Imaging in AD
Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS Study
Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy Controls
Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation
Clinical Trials (8)
Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT
Neuroinflammation Imaging in AD
Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS Study
Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy Controls
Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation
iNOS With Positron Emission Tomography (PET) in Cellular Inflammation.
Assessing NOS Uptake With PET Imaging in Lung Inflammation
PET Imaging of Endotoxin-induced iNOS Activation
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8